Search results
Results from the WOW.Com Content Network
Second-generation sulfonylureas have increased potency by weight, compared to first-generation sulfonylureas. [21] Similarly, ACCORD (Action to Control Cardiovascular Risk in Diabetes) [ 22 ] and the VADT (Veterans Affairs Diabetes Trial) [ 23 ] studies showed no reduction in heart attack or death in patients assigned to tight glucose control ...
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. [1] It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).
It is classified as a second-generation sulfonylurea. [4] Glimepiride was patented in 1979 and approved for medical use in 1995. [5] It is available as a generic medication. [2] In 2022, it was the 64th most commonly prescribed medication in the United States, with more than 10 million prescriptions. [6] [7]
Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. [7] It is used when dietary changes, exercise, and weight loss are not enough. [4] It is taken by mouth. [7] Side effect may include low blood sugar, vomiting, abdominal pain, rash, and liver problems.
Sulfonylurea herbicides (5 P) Pages in category "Sulfonylureas" The following 6 pages are in this category, out of 6 total. This list may not reflect recent changes. ...
Eight types of these pills have been marketed in North America, but not all remain available. The "second-generation" sulfonylureas are now more commonly used. They are more effective than first-generation drugs and have fewer side-effects. All may cause weight gain. [citation needed]
It's New for '67! Chevrolet unveiled the Camaro in September 1966. The car carried a base price of $2,466 (about $22,043 today) and offered a wide range of options, including a choice of 15 ...
Chlorpropamide and other sulfonylureas encourage weight gain, so they are generally not favored for use in very obese patients. Metformin (Glucophage) is considered a better drug for these patients. Sulfonylureas should be used with caution or generally avoided in patients with hepatic and renal impairment, patients with porphyria , patients ...